Cargando…
Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma
BACKGROUND: The pathogenesis of primary tuberculous pleurisy is a delayed-type hypersensitivity immunogenic reaction to a few mycobacterial antigens entering the pleural space rather than direct tissue destruction by mycobacterial proliferation. Although it has been shown that pulmonary tuberculosis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568019/ https://www.ncbi.nlm.nih.gov/pubmed/23317113 http://dx.doi.org/10.1186/1471-2334-13-12 |
_version_ | 1782258750674960384 |
---|---|
author | Shinohara, Tsutomu Shiota, Naoki Kume, Motohiko Hamada, Norihiko Naruse, Keishi Ogushi, Fumitaka |
author_facet | Shinohara, Tsutomu Shiota, Naoki Kume, Motohiko Hamada, Norihiko Naruse, Keishi Ogushi, Fumitaka |
author_sort | Shinohara, Tsutomu |
collection | PubMed |
description | BACKGROUND: The pathogenesis of primary tuberculous pleurisy is a delayed-type hypersensitivity immunogenic reaction to a few mycobacterial antigens entering the pleural space rather than direct tissue destruction by mycobacterial proliferation. Although it has been shown that pulmonary tuberculosis induces 18-fluorodeoxyglucose (FDG) uptake in active lesions, little is known about the application of FDG positron emission/computed tomography (FDG PET/CT) to the management of primary tuberculous pleurisy. CASE PRESENTATION: We report a case of asymptomatic primary tuberculous pleurisy presenting with diffuse nodular pleural thickening without distinct pleural effusion and parenchymal lung lesions mimicking malignant mesothelioma. An initial FDG PET/CT scan demonstrated multiple lesions of intense FDG uptake in the right pleura and thoracoscopic biopsy of pleural tissue revealed caseous granulomatous inflammation. The patient received antituberculous therapy for 6 months, with clearly decreased positive signals on a repeated FDG PET/CT scan. CONCLUSION: FDG PET/CT imaging may be useful for evaluating disease activity in tuberculous pleurisy patients with an unknown time of onset. |
format | Online Article Text |
id | pubmed-3568019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35680192013-02-12 Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma Shinohara, Tsutomu Shiota, Naoki Kume, Motohiko Hamada, Norihiko Naruse, Keishi Ogushi, Fumitaka BMC Infect Dis Case Report BACKGROUND: The pathogenesis of primary tuberculous pleurisy is a delayed-type hypersensitivity immunogenic reaction to a few mycobacterial antigens entering the pleural space rather than direct tissue destruction by mycobacterial proliferation. Although it has been shown that pulmonary tuberculosis induces 18-fluorodeoxyglucose (FDG) uptake in active lesions, little is known about the application of FDG positron emission/computed tomography (FDG PET/CT) to the management of primary tuberculous pleurisy. CASE PRESENTATION: We report a case of asymptomatic primary tuberculous pleurisy presenting with diffuse nodular pleural thickening without distinct pleural effusion and parenchymal lung lesions mimicking malignant mesothelioma. An initial FDG PET/CT scan demonstrated multiple lesions of intense FDG uptake in the right pleura and thoracoscopic biopsy of pleural tissue revealed caseous granulomatous inflammation. The patient received antituberculous therapy for 6 months, with clearly decreased positive signals on a repeated FDG PET/CT scan. CONCLUSION: FDG PET/CT imaging may be useful for evaluating disease activity in tuberculous pleurisy patients with an unknown time of onset. BioMed Central 2013-01-14 /pmc/articles/PMC3568019/ /pubmed/23317113 http://dx.doi.org/10.1186/1471-2334-13-12 Text en Copyright ©2013 Shinohara et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Shinohara, Tsutomu Shiota, Naoki Kume, Motohiko Hamada, Norihiko Naruse, Keishi Ogushi, Fumitaka Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title | Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title_full | Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title_fullStr | Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title_full_unstemmed | Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title_short | Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
title_sort | asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568019/ https://www.ncbi.nlm.nih.gov/pubmed/23317113 http://dx.doi.org/10.1186/1471-2334-13-12 |
work_keys_str_mv | AT shinoharatsutomu asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma AT shiotanaoki asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma AT kumemotohiko asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma AT hamadanorihiko asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma AT narusekeishi asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma AT ogushifumitaka asymptomaticprimarytuberculouspleurisywithintense18fluorodeoxyglucoseuptakemimickingmalignantmesothelioma |